Serum glial fibrillary acidic protein is sensitive to acute but not chronic tissue damage in cerebral small vessel disease

BACKGROUND: Serum glial fibrillary acidic protein (sGFAP) has been proposed as a biomarker in various neurological diseases but has not yet been systematically investigated in patients with cerebral small vessel disease (CSVD). We explored whether sGFAP levels are increased in stroke patients with M...

Descripción completa

Detalles Bibliográficos
Autores principales: Gattringer, Thomas, Enzinger, Christian, Pinter, Daniela, Fandler-Höfler, Simon, Kneihsl, Markus, Haidegger, Melanie, Eppinger, Sebastian, Demjaha, Rina, Buchmann, Arabella, Jerkovic, Andrea, Schmidt, Reinhold, Khalil, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813007/
https://www.ncbi.nlm.nih.gov/pubmed/36056929
http://dx.doi.org/10.1007/s00415-022-11358-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813007/
https://www.ncbi.nlm.nih.gov/pubmed/36056929
http://dx.doi.org/10.1007/s00415-022-11358-7

Ejemplares similares